Αποτελέσματα Αναζήτησης
The 2025 edition of ICD-10-CM D57.2 became effective on October 1, 2024. This is the American ICD-10-CM version of D57.2 - other international versions of ICD-10 D57.2 may differ. One of the sickle cell disorders characterized by the presence of both hemoglobin s and hemoglobin c.
- D57.40
D57.40 is a billable/specific ICD-10-CM code that can be...
- D57.40
Hemoglobin S-C disease is suspected in patients whose clinical features suggest sickle cell disease or whose red blood cells demonstrate sickling. Stained blood smears show target cells, spherocytes, and rarely sickle cells or oat-shaped cells.
Clinical Information. One of the sickle cell disorders characterized by the presence of both hemoglobin s and hemoglobin c. It is similar to, but less severe than sickle cell anemia. ICD-10-CM D57.20 is grouped within Diagnostic Related Group (s) (MS-DRG v42.0): 811 Red blood cell disorders with mcc. 812 Red blood cell disorders without mcc.
The higher level of hemoglobin in HbSC compared to SCA patients is striking since 90% of HbSC patients had hemoglobin levels above 10 g/dL with a general agreement that 10–11g/dL would represent a threshold for vaso-occlusive outcomes.24 Therefore, a hemoglobin target below this level seems to be a rational therapeutical goal that can be ...
People with this disease have atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape. Signs and symptoms of sickle cell disease usually begin in early childhood.
HbC disease, defined as homozygosity for the HbC gene, causes mild hemolytic anemia; simple heterozygosity for HbC (HbC trait, HbAC) is innocuous.
4 Οκτ 2022 · Sickle cell disease (SCD) is an inherited group of disorders characterized by the presence of hemoglobin S (Hb S), either from homozygosity for the sickle mutation (Hb SS) or compound heterozygosity with another beta globin variant (eg, sickle-beta thalassemia, Hb SC disease).
